Béguelin et al. investigated the relationship between DLBCL and Bcl-2 and found that mutant EZH2 had a stronger inhibitory effect on differentiating B-cell lymphoma cells. This evidence concerns the gene EZH2 and B-cell non-Hodgkin lymphoma.